Annual report pursuant to Section 13 and 15(d)

Stockholders' Equity (Deficiency) (Details Textual 1)

v3.7.0.1
Stockholders' Equity (Deficiency) (Details Textual 1)
12 Months Ended
Apr. 12, 2017
USD ($)
$ / shares
shares
Jul. 15, 2015
$ / shares
shares
Sep. 30, 2014
$ / shares
shares
Jun. 30, 2017
USD ($)
$ / shares
shares
Jun. 30, 2016
USD ($)
$ / shares
shares
Jun. 30, 2016
USD ($)
$ / shares
CAD / shares
shares
Jun. 30, 2017
CAD / shares
Jun. 30, 2016
CAD / shares
Jun. 30, 2015
USD ($)
$ / shares
shares
Mar. 31, 2013
$ / shares
Stockholders Equity Note [Line Items]                    
Total cash commission         $ 80,575          
Issuance of agent warrants | shares       138,462 23,477          
Warrants exercise, term       5 years            
Exercise price | $ / shares   $ 3.00   $ 4.06 $ 3.00 $ 3.00     $ 3.00  
Issuance of cash       $ 347,897 $ 582,511          
Net proceeds of cash       7,932,107 1,903,514          
Gross proceeds of cash       1,492,298 2,566,660          
Issuance of agent warrants cost       424,401 29,594          
Series B preferred stock dividend                
Preferred stock, par value | $ / shares       $ 0.001 $ 0.001 $ 0.001        
Common stock, shares authorized | shares       50,000,000 50,000,000 50,000,000        
Common stock, par value | $ / shares       $ 0.001 $ 0.001 $ 0.001        
Common Stock, Shares, Issued | shares       14,509,633 11,187,023 11,187,023        
Common stock issued and outstanding exchanged basis | shares       982,761 1,014,011 1,014,011        
Deferred costs             $ 550,119  
Shares issued for services       $ 564,000 146,900          
Stock option recognized as additional paid in capital       124,747 394,132          
Stock option liability expense       85,094 377,927          
Proceeds from warrant exercises       $ 545,026 $ 579,309          
Number of warrants issued | shares         265,000          
Revaluation loss of stock option         $ 377,927          
Amendment shares of stock option exercise price | shares       43,750 87,500 87,500        
Reclassified to equity value       $ 260,969 $ 175,875          
Additional stock option were amended remaining stock option liability being reclassified to equity | shares         43,750          
2017 Public Offering [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares $ 3.50                  
Gross proceeds of cash $ 9,000,000                  
Common stock, par value | $ / shares $ 3.25                  
Additional warrants purchase | shares 2,076,924                  
Issuance of shares and warrants - net of issue costs, shares | shares 2,769,232                  
Stock options [Member]                    
Stockholders Equity Note [Line Items]                    
Threshold percentage of share capital on fully diluted basis for common stock authorized to issue         7.50%          
Number of stock options outstanding | shares       1,120,850 856,250 856,250     898,750  
Aggregate intrinsic value of stock options outstanding       $ 56,783 $ 3,486,910 $ 3,486,910        
Aggregate intrinsic value of stock options exercisable       56,783 2,941,031 $ 2,941,031        
Unrecognized compensation expense       $ 334,518            
Unrecognized compensation expense, term       2 years 8 months 2 days            
Aggregate intrinsic value of unvested stock options       $ 0 $ 547,279          
Weighted average contractual term       9 years 4 months 6 days 9 years 6 months 3 days          
Stock options [Member] | 1.54 [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | CAD / shares               CAD 2.00    
Number of stock options outstanding | shares       25,000            
Unit offering price | CAD / shares           $ 0.50        
Warrants                    
Stockholders Equity Note [Line Items]                    
Exercise price | (per share)       $ 5.93       CAD 2.00    
Warrants expiration date       Jul. 31, 2020            
Shares issued for services       $ 41,400 $ 265,000          
Proceeds from warrant exercises       $ 146,250 $ 125,001          
Warrants | Initial Public Offering [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares         $ 3.00 $ 3.00        
Common stock, par value | $ / shares         $ 0.001 $ 0.001        
Common stock shares issued on exercise of warrants | shares       48,750 41,667          
Valent Technologies, LLC [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | (per share)       $ 1.54     CAD 2.00      
Proceeds from warrant exercises       $ 192,075            
Valent Technologies, LLC [Member] | Warrants                    
Stockholders Equity Note [Line Items]                    
Warrants expiration date         Feb. 01, 2017          
Number of warrants issued | shares         125,000          
Series A Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares issued | shares       278,530 278,530 278,530        
Preferred Stock, rate of dividend     3.00%              
Series A Preferred Stock [Member] | Valent Technologies, LLC [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares issued | shares     278,530              
Preferred stock, par value | $ / shares     $ 1.00              
Preferred Stock, rate of dividend     3.00%              
Series B Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Preferred stock, shares issued | shares       881,113 902,238 902,238        
Preferred Stock, rate of dividend         9.00%          
Series B Preferred Stock [Member] | Warrants                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares         $ 4.00 $ 4.00        
Common stock [Member]                    
Stockholders Equity Note [Line Items]                    
Series B preferred stock dividend, shares | shares       200,446 30,360          
Series B preferred stock dividend       $ 200 $ 31          
Common stock, par value | $ / shares   $ 2.40                
Common stock shares issued on exercise of warrants | shares   1,069,417                
Issuance of shares and warrants - net of issue costs, shares | shares         1,069,417          
Shares issued for services, shares | shares       60,000 27,500          
Stock option recognized as additional paid in capital                
Issuance of shares and warrants - net of issue costs, shares | shares       2,769,232 1,069,417          
Accumulated deficit [Member]                    
Stockholders Equity Note [Line Items]                    
Series B preferred stock dividend       $ (790,454) $ 238,326          
Stock option recognized as additional paid in capital                
2017 Agent Warrants [Member]                    
Stockholders Equity Note [Line Items]                    
Sale of stock description       Under the Company's engagement agreement with the placement agent, the Company agreed to pay up to an 8% cash commission and issue warrants to purchase shares of common stock (the "2017 Agent Warrants") up to the number of shares of common stock equal to 5% of the aggregate number of shares issued in the 2017 Public Offering.            
2016 Agent Warrants [Member]                    
Stockholders Equity Note [Line Items]                    
Sale of stock description         Under the Company's engagement agreements with these placement agents, the Company agreed to pay up to a 7% cash commission and issue warrants to purchase shares of common stock (the "2015 Agent Warrants") up to the number of shares of our common stock equal to 5% of the aggregate.          
Warrants expiration date         Jul. 15, 2020          
2016 Agent Warrants [Member] | Series B Preferred Stock [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares       $ 4.00            
Warrants expiration date       May 12, 2021            
2013 Placement Agent Warrants [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares         $ 3.144 $ 3.144        
Investor Warrant Amendments [Member]                    
Stockholders Equity Note [Line Items]                    
Warrants expiration date         Mar. 31, 2019          
Number of stock options outstanding | shares         181,156 181,156        
Number of warrants issued | shares       15,944 767,560          
Investor Warrants [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares       $ 3.50           $ 0.004
Warrants expiration date       Apr. 19, 2022            
Agent Warrants [Member]                    
Stockholders Equity Note [Line Items]                    
Exercise price | $ / shares       $ 4.06            
Warrants expiration date       Apr. 12, 2022